Biomarkers and targets for diagnosis, prognosis and...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2707069

Disclosed are diagnostic techniques for the detection of human prostate disease. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in metastatic prostate cancer compared to normal human prostate, benign prostatic hyperplasia, and non-metastatic prostate cancer. The invention also relates to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with the disease state compared to normal healthy individuals. Described are methods of therapeutic use for genes identified as differentially expressed in metastatic prostate cancer, and means for screening pharmaceuticals effective in treatment of prostate cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers and targets for diagnosis, prognosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers and targets for diagnosis, prognosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers and targets for diagnosis, prognosis and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1600869

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.